Thomas Bradley

1.5k total citations
55 papers, 967 citations indexed

About

Thomas Bradley is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Thomas Bradley has authored 55 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Thomas Bradley's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Cancer Treatment and Pharmacology (6 papers). Thomas Bradley is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Cancer Treatment and Pharmacology (6 papers). Thomas Bradley collaborates with scholars based in United States, United Kingdom and Australia. Thomas Bradley's co-authors include Benjamin Bonavida, Daniel R. Budman, K K Davidson, J. McGill, B Forseth, Geoffrey M. Wahl, Daniel D. Von Hoff, Elizabeth A. Grimm, Anne L. Golden and Iuliana Shapira and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Thomas Bradley

49 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Bradley United States 18 283 249 179 122 99 55 967
G C White United States 26 573 2.0× 129 0.5× 137 0.8× 70 0.6× 100 1.0× 51 2.7k
Melchior Lauten Germany 19 250 0.9× 110 0.4× 169 0.9× 72 0.6× 110 1.1× 46 1.0k
Zhen Ni Zhou United States 13 172 0.6× 490 2.0× 398 2.2× 98 0.8× 84 0.8× 27 996
Thomas A. Lane United States 23 322 1.1× 399 1.6× 300 1.7× 76 0.6× 187 1.9× 90 1.9k
Karon Abe United States 18 475 1.7× 97 0.4× 119 0.7× 69 0.6× 102 1.0× 46 1.2k
Kelly L. Bolton United States 19 384 1.4× 97 0.4× 528 2.9× 353 2.9× 167 1.7× 69 1.7k
Celia I. Kaye United States 24 658 2.3× 92 0.4× 236 1.3× 95 0.8× 126 1.3× 59 2.1k
Robert Debernardo United States 17 228 0.8× 428 1.7× 212 1.2× 55 0.5× 153 1.5× 39 1.2k
David L. Cooper United States 30 867 3.1× 101 0.4× 208 1.2× 68 0.6× 78 0.8× 133 2.7k
Elena Vasilieva Russia 17 440 1.6× 320 1.3× 66 0.4× 102 0.8× 51 0.5× 83 1.0k

Countries citing papers authored by Thomas Bradley

Since Specialization
Citations

This map shows the geographic impact of Thomas Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bradley more than expected).

Fields of papers citing papers by Thomas Bradley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bradley. The network helps show where Thomas Bradley may publish in the future.

Co-authorship network of co-authors of Thomas Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Bradley. A scholar is included among the top collaborators of Thomas Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Bradley. Thomas Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mirza, Hasan, Darren Ennis, Philip Smith, et al.. (2022). The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma. Clinical Cancer Research. 28(13). 2911–2922. 28 indexed citations
3.
Kleckner, Amber S., Eva Culakova, Jason Zittel, et al.. (2022). The relationship between comorbidities and other aging-related conditions among patients with advanced cancer. Journal of Geriatric Oncology. 13(7). 1066–1069. 4 indexed citations
4.
Bradley, Thomas & Simon Moxon. (2020). FilTar: using RNA-Seq data to improve microRNA target prediction accuracy in animals. Bioinformatics. 36(8). 2410–2416. 3 indexed citations
5.
Fowler, Emily K., Thomas Bradley, Simon Moxon, & Tracey Chapman. (2019). Divergence in Transcriptional and Regulatory Responses to Mating in Male and Female Fruitflies. Scientific Reports. 9(1). 16100–16100. 25 indexed citations
6.
Seguin, Alexandra, Naoko Takahashi‐Makise, Yvette Y. Yien, et al.. (2017). Reductions in the mitochondrial ABC transporter Abcb10 affect the transcriptional profile of heme biosynthesis genes. Journal of Biological Chemistry. 292(39). 16284–16299. 27 indexed citations
7.
Bradley, Thomas & Simon Moxon. (2017). An Assessment of the Next Generation of Animal miRNA Target Prediction Algorithms. Methods in molecular biology. 1580. 175–191. 2 indexed citations
8.
Burch, Gerald F., Jana J. Burch, Thomas Bradley, & Nathan A. Heller. (2014). Identifying and Overcoming Threshold Concepts and Conceptions. Organizational Behavior Teaching Review. 39(4). 476–496. 17 indexed citations
9.
Kritharis, Athena, Thomas Bradley, & Daniel R. Budman. (2013). The evolving use of arsenic in pharmacotherapy of malignant disease. Annals of Hematology. 92(6). 719–730. 28 indexed citations
10.
Barginear, Myra F., Richard J. Gralla, Thomas Bradley, et al.. (2012). Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Supportive Care in Cancer. 20(11). 2865–2872. 64 indexed citations
11.
Kim, Brian H., Thomas Bradley, Julia Tai, & Daniel R. Budman. (2009). Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review. Oncology. 76(4). 231–238. 53 indexed citations
12.
Tomlinson, Christopher, Manjula Thimma, Jayne L. Dennis, et al.. (2008). MiMiR – an integrated platform for microarray data sharing, mining and analysis. BMC Bioinformatics. 9(1). 379–379. 15 indexed citations
13.
Barginear, Myra F., Thomas Bradley, Iuliana Shapira, & Daniel R. Budman. (2008). Implications of applied research for prognosis and therapy of breast cancer. Critical Reviews in Oncology/Hematology. 65(3). 223–234. 7 indexed citations
14.
Bradley, Thomas, et al.. (2004). Overview of smoking and all cancers. Medical Clinics of North America. 88(6). 1655–1675. 40 indexed citations
15.
Khurana, Vikas, María de la Fuente, & Thomas Bradley. (1999). Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis. The American Journal of Medicine. 106(1). 118–119. 9 indexed citations
16.
Choi, Kwang Nam, Marvin Rotman, Hassan A. Aziz, et al.. (1997). Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors. International Journal of Radiation Oncology*Biology*Physics. 39(4). 823–829. 28 indexed citations
17.
Verma, Ram S., et al.. (1991). del(2)(p23): A consistent recurrent abnormality in acute myelogenous leukemia. Cancer Genetics and Cytogenetics. 57(2). 175–179. 6 indexed citations
18.
Bonavida, Benjamin, L T Lebow, & Thomas Bradley. (1984). Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.. The Journal of Immunology. 132(2). 594–598. 5 indexed citations
19.
Bonavida, Benjamin, Thomas Bradley, & Elizabeth A. Grimm. (1983). The single-cell assay in cell-mediated cytotoxicity. Immunology Today. 4(7). 196–200. 41 indexed citations
20.
Bonavida, Benjamin & Thomas Bradley. (1980). Assessment of cell-mediated cytotoxicity. Immunology Today. 1(5). 104–109. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G C White Breakdown of academic impact, for papers by Melchior Lauten Breakdown of academic impact, for papers by Zhen Ni Zhou Breakdown of academic impact, for papers by Thomas A. Lane Breakdown of academic impact, for papers by Karon Abe Breakdown of academic impact, for papers by Kelly L. Bolton Breakdown of academic impact, for papers by Celia I. Kaye Breakdown of academic impact, for papers by Robert Debernardo Breakdown of academic impact, for papers by David L. Cooper Breakdown of academic impact, for papers by Elena Vasilieva
Rankless by CCL
2026